Skip to content
Screener

Reported August 6, 2026 · After market close

Revenue$72.1MMiss by $2.4M
EPS-$0.02Beat by $0.01
Revenue estimate$74.5M
EPS estimate-$0.03
Our second quarter results reflect continued sales pressure, while adjusted EBITDA came in well above our guidance range as we improved gross margin and maintained disciplined operating expense management. Our strategic priorities remain clear. We are focused on strengthening the core Hydrafacial franchise, increasing the productivity of our installed base and expanding our portfolio with complementary technologies. Supported by our trusted brand, global provider network and recurring consumables business, we believe these priorities position SkinHealth Systems to deliver more sustainable and diversified long-term growth.
Pedro Malha

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$67.8M
EPS estimate-$0.07

Financials

Q2 2026

Income statement

See full
Revenue$72.1M-7.8%
Gross profit$49.3M+0.5%
Operating income$3.6M+232%
Net income-$2.7M-114%
EPS (diluted)-$0.02-167%

Balance sheet

See full
Cash & equivalents$206.1M-2.8%
Total debt$124.9M-66.8%
Total equity$55.6M-24.9%
Total assets$486.6M-4.1%

Cash flow

See full
CapEx$427.0K+364%

Valuation & ratios

Valuation

as of 09/16/26
See full
Market cap$87.85M-71.4%
Enterprise value$6.69M-98.6%
P/S0.3×-0.7×

Profitability

See full
Gross margin66.4%+4.9pp
Operating margin-1.5%-0.7pp
Net margin-9.8%+14.7pp

Returns & leverage

See full
Return on equity-43.9%+82.7pp
Debt / equity2.2×-2.8×
Current ratio1.8×-3.4×

Segments

By geography

See full
Americas$49.9M-4.2%
Europe, the Middle East and Africa$14.9M-19.0%
Asia-Pacific$7.3M-5.4%

By product

See full
Consumables$53.9M-3.5%
Delivery Systems$18.3M-18.4%

FAQ

When did The Beauty Health Company report Q2 2026 earnings?
The Beauty Health Company (SKIN) reported Q2 2026 earnings on August 6, 2026 after market close.
What were The Beauty Health Company's Q2 2026 revenue and EPS?
The Beauty Health Company reported revenue of $72.1M and eps of $-0.02 for Q2 2026.
Did The Beauty Health Company beat estimates in Q2 2026?
Revenue missed the consensus estimate of $74.5M by $2.4M. EPS beat the consensus estimate of $-0.03 by $0.01.
How did The Beauty Health Company's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 7.8% from $78.2M a year earlier.
Where can I find The Beauty Health Company's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-054309) and the 10-Q periodic report (0001628280-26-054476) directly on SEC EDGAR. The filing index links above go to sec.gov.